Option chain shows key data for Royal Bank of Canada Non Cum 1st Pfd Registered Shs Series -AZ-'s stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Royal Bank of Canada Non Cum 1st Pfd Registered Shs Series -AZ-.

Royal Bank of Canada Non Cum 1st Pfd Registered Shs Series -AZ- (OTC:RYBPF) Stock, Option Chain

Royal Bank of Canada Non Cum 1st Pfd Registered Shs Series -AZ-

Macro Economic Events

News

Global

Economics

China's Xi Says China Will Improve Institutional Mechanism For Opening Up To The Outside World At A High Level; China Will Expand Unilateral Opening Up To The Least Developed Countries

Evercore ISI Group analyst David Palmer maintains Post Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/POST#NYSE">POST</a>) with a Outperform and raises the price target from $123 to $126.

Price Target

Analyst Ratings

POST

Evercore ISI Group Maintains Outperform on Post Hldgs, Raises Price Target to $126

Royal Caribbean Cruises Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) stock has surged to an all-time high of $238.10 in November following Donald Trump's <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41772701/trumps-historic-return-7-ways-his-second-term-could-impact-the-us-economy">presidential election win</a>, as investors anticipate a favorable economic environment for the travel and leisure industry. 
Trump's pro-business policies, including proposed tax cuts for individuals and corporations, could increase disposable income for consumers, potentially driving a surge in discretionary spending on cruises and vacations.
What To Know: Trump's emphasis on deregulation is also seen as a positive for Royal Caribbean. Easing restrictions on the travel industry, particularly those introduced during the pandemic, could streamline operations and reduce compliance costs. This regulatory flexibility may help the cruise operator expand routes and develop new destinations, enhancing its competitive edge.
Read Also: <a href="https://www.benzinga.com/24/11/42035375/how-to-earn-500-a-month-from-walmart-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Walmart Stock Ahead Of Q3 Earnings</a>
Additionally, Trump's stance on energy production could benefit Royal Caribbean by keeping fuel prices stable or even reducing them. With fuel being a significant operating expense for cruise lines, lower energy costs could directly improve Royal Caribbean's profit margins.
The potential rollback of environmental regulations may also have implications for Royal Caribbean's fleet upgrades. While the company has committed to sustainability initiatives, relaxed emissions standards could reduce the urgency and cost of compliance, freeing up resources for growth and marketing.
Furthermore, Trump's broader economic policies, including infrastructure investments, could indirectly benefit Royal Caribbean by enhancing port facilities and boosting international trade and travel. If Trump's administration fosters stronger consumer confidence and economic growth, Royal Caribbean could capitalize on the demand for leisure travel.
Read Also: <a href="https://www.benzinga.com/24/11/42032477/spirit-airlines-eyes-financial-stability-with-chapter-11-filing-and-equity-injection">Spirit Airlines Eyes Restructuring With Chapter 11 Filing And Equity Injection</a>
<h2 class="wp-block-heading">How To Buy RCL Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Royal Caribbean&#8217;s case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, RCL has a 52-week high of $238.10 and a 52-week low of $102.77.

Why Royal Caribbean Cruises (RCL) Stock Hit A New All-Time High This Month

&nbsp;
Item 1.05 Material Cybersecurity Incident.
&nbsp;
iLearningEngines, Inc. (the "Company") recently became aware of a cybersecurity incident. &nbsp;The ongoing investigation has revealed that a threat actor illegally accessed the Company's environment and certain files on its network, misdirected a $250,000 wire payment, and deleted a number of email messages.&nbsp; The wire payment has not been recovered.
&nbsp;
When it learned of the incident, which has been contained, the Company activated its cybersecurity response plan and launched an internal investigation. The Company engaged a nationally recognized forensic firm and other external advisors to assess and remediate the unauthorized activity. The Company's ongoing investigation and response include continued assessment of impacted systems and data.
&nbsp;
The Company has incurred, and may continue to incur, certain expenses related to its response to this incident. Based on the information available to date, the Company believes that the cybersecurity incident will have a material impact on its operations during the quarter ended December 31, 2024 but does not expect the incident to have a material impact on full year 2024 results. The Company remains subject to various risks due to the incident, including diversion of management's attention, potential litigation, changes in customer or investor behavior, and regulatory scrutiny.

AILE

iLearningEngines Recently Became Aware Of A Cybersecurity Incident; The Ongoing Investigation Has Revealed That A Threat Actor Illegally Accessed The Co's Environment And Certain Files On Its Network, Misdirected A $250,000 Wire Payment, And Deleted A Number Of Email Messages; The Wire Payment Has Not Been Recovered

Evercore ISI Group analyst Vijay Jayant maintains Walt Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) with a Outperform and raises the price target from $128 to $134.

Evercore ISI Group Maintains Outperform on Walt Disney, Raises Price Target to $134

Bonnie-Jeanne Gerety Appointed Interim CFO
Thomas Olivier Appointed Interim COO
Postpones Announcement of 3rd Quarter 2024 Financial Results
BETHESDA, Md., Nov. 18, 2024 (GLOBE NEWSWIRE) -- iLearningEngines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AILE#NASDAQ">AILE</a>) ("iLearningEngines," "ILE" or the "Company") a leader in AI-powered learning and work automation, today announced the appointment of Bonnie-Jeanne Gerety as Interim Chief Financial Officer ("CFO") and the appointment of Thomas Olivier as Interim Chief Operating Officer ("COO"). Farhan Naqvi will continue to serve ILE as Senior Vice President of Corporate Development.

Management

iLearningEngines Announces Bonnie-Jeanne Gerety Appointed Interim CFO; Thomas Olivier Appointed Interim COO; Postpones Announcement Of Q3 2024 Financial Results

Stephens &amp; Co. analyst Sudan Loganathan initiates coverage on Kymera Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KYMR#NASDAQ">KYMR</a>) with a Overweight rating and announces Price Target of $65.

Initiation

KYMR

Stephens & Co. Initiates Coverage On Kymera Therapeutics with Overweight Rating, Announces Price Target of $65

D. Boral Capital analyst Jason Kolbert initiates coverage on CervoMed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVO#NASDAQ">CRVO</a>) with a Buy rating and announces Price Target of $34.

CRVO

D. Boral Capital Initiates Coverage On CervoMed with Buy Rating, Announces Price Target of $34

Mary Buffett might not have left her marriage with a lifetime of See's Candies. Still, she did gain something equally valuable: an insider's perspective on <a href="https://www.benzinga.com/news/24/11/41884428/warren-buffetts-166-billion-warning-to-wall-street-has-hit-a-fever-pitch-and-the-financial-world-cant-afford-to-ignore-it">Warren Buffett's investing genius</a>.&nbsp;
<a href="https://www.benzinga.com/personal-finance/24/10/41198368/warren-buffetts-son-who-famously-cashed-in-his-90-000-inheritance-at-19-spends-millions-in-buffe">Married to Warren's son</a>, Peter, from 1980 to 1993, Mary wasn't just an observer; she absorbed the legendary investor's philosophies and made them her own, eventually turning her experience into a successful career as an author, speaker and educator.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
<li><a href="https://www.benzinga.com/money/cd-valet-growth">CD Popularity Soars: Over 50 Million Americans Embrace Safe Savings with 5–10% Annual Growth</a></li>
</ul>
In a 2019 ThinkAdvisor interview, Mary Buffett offered a glimpse into what it was like to be the daughter-in-law of the billionaire ‘Oracle of Omaha.'
In the early days, Mary had little idea how singular Warren's approach to life – and gift-giving – would be. When she joined the Buffett family, she admits she assumed perks like endless See's Candies would be part of the package. "When I married him, the only thing I knew was that his father owned See's Candies," she recalled. "So when we got married, I was like, great – free candy! Never knowing that there was no free candy with Warren." Instead of sweets, Mary got a front-row seat to the value-investing strategies that have defined Warren's career.
Trending: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.
Though she'd already had a solid foundation in business from her work at Columbia Records to running music publishing at Hugh Hefner's company, Warren's <a href="https://www.benzinga.com/money/can-you-guess-how-many-americans-successfully-retire-with-1-million-saved">relentless focus on investing</a> soon became a major influence in her life.&nbsp;
Mary says that investing was pretty much all he talked about. She shared in the interview, "That's all he talked about! A couple of times a year we'd go to Omaha and he'd come home and get right on the phone, talking to either Mrs. [Katharine] Graham of the Washington Post or Stan Lipsey [publisher] of The Buffalo News [which Buffett bought in 1977]. He'd be on the phone when you were in the den with him."
Trending: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." <a href="https://www.benzinga.com/money/connect-invest-real-estate-notes">These high-yield real estate notes that pay 7.5% &#8211; 9% make earning passive income easier than ever.</a>
<a href="https://www.benzinga.com/personal-finance/24/11/41850076/warren-buffett-jokes-hed-be-eating-thanksgiving-dinner-at-mcdonalds-if-it-wasnt-for-uncle-sam-stepping-up">Holidays with the Buffetts</a> were a mini business summit, where conversations with industry titans flowed over dinner instead of eggnog. "When the family got together in Laguna over Christmastime, all the industry titans would be there: We'd have lunches and dinners and they'd all talk about companies. Investing was the only thing Warren ever talked about!" she said.
All that immersion in the investing world paid off for Mary. Inspired by Warren's success and principles, she built her unique career. Today, she's an international speaker and bestselling author of multiple books on Warren Buffett's investment strategies. Her first book, Buffettology, was published in 1997 and became a massive success, leading to a series of books. Her latest, 7 Secrets to Investing Like Warren Buffett, offers readers an accessible entry point into Warren's world of value investing.
See Also: <a href="https://www.benzinga.com/money/100k-cd">$100K Sitting In A CD Account, Should I Move Money Into The Stock Market?</a>
Mary's takeaways from her years with the Buffetts come down to timeless principles: patience, discipline and the value of understanding the people behind a business. "The biggest part was watching his discipline and patience and not doing things quickly," she explained. "He'd conduct research and understand the people who were running a company. All of that mattered so much to his success."
While Mary may not have <a href="https://www.benzinga.com/personal-finance/24/06/39551391/warren-buffett-swears-by-his-junk-food-diet-if-id-been-eating-broccoli-and-brussels-sprouts-all-">left the marriage with free chocolate</a>, her time with Warren ultimately gave her something sweeter: the knowledge to build a career helping others understand one of the world's greatest investors.
Read Next:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a></li>
</ul>

Personal Finance

Warren Buffett's Daughter-in-Law Thought She'd Get 'Free Candy' When She Married His Son – Turns Out, 'There Was No Free Candy With Warren'

Shares of Tesla, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) rose sharply in today's pre-market trading after a report on Sunday, suggested that the upcoming regulatory framework might ease <a href="https://www.benzinga.com/markets/equities/24/11/42028797/tesla-soars-over-5-in-overnight-trading-as-trump-administration-reportedly-seeks-to-ease-fsd-norms">mandates for self-driving vehicles</a>.
The transition team of President-elect Donald Trump has told advisors that it aims to make a framework for fully self-driving vehicles a priority for the Transportation Department, reported Bloomberg, citing people familiar with the matter.
Tesla shares jumped 8.2% to $347.13 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Apollomics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLM#NASDAQ">APLM</a>) gained 80.3% to $0.1725 in pre-market trading after declining 8% on Friday.</li>
<li>Mobile-health Network Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDR#NASDAQ">MNDR</a>) rose 63% to $0.4238 in pre-market trading after dipping around 12% on Friday.</li>
<li>AtlasClear Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATCH#NYSE">ATCH</a>) gained 51.1% to $0.2720 in pre-market trading.</li>
<li>DDC Enterprise Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDC#NYSE">DDC</a>) gained 29.1% to $0.2655 in pre-market trading.</li>
<li>Liberty Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LBRT#NYSE">LBRT</a>) gained 28% to $21.63 in pre-market trading.</li>
<li>VivoPower International PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VVPR#NASDAQ">VVPR</a>) gained 15.1% to $0.9450 in pre-market trading after dipping 39% on Friday.</li>
<li>Intellia Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) climbed 12.7% to $15.75 in pre-market trading after the company said initial Phase 1 data suggesting Nexiguran Ziclumeran, an in vivo CRISPR/Cas9 gene editing therapy, may benefit ATTR Amyloidosis Progression.</li>
<li>Aethlon Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEMD#NASDAQ">AEMD</a>) gained 12.7% to $0.45 in pre-market trading.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) gained 11.1% to $20.64 in pre-market trading after gaining more than 3% on Friday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Fly-E Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYE#NASDAQ">FLYE</a>) shares tumbled 33.2% to $0.4600 in pre-market trading after gaining around 13% on Friday.</li>
<li>CareMax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMAX#NASDAQ">CMAX</a>) shares fell 28.5% to $1.20 in pre-market trading. CareMax reached agreements to sell Management Services Organization and Core Centers&#8217; assets.</li>
<li>Paramount Gold Nevada Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PZG#NYSE">PZG</a>) shares fell 27.8% to $0.3301 in pre-market trading after gaining around 4% on Friday.</li>
<li>QMMM Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMMM#NASDAQ">QMMM</a>) declined 23.4% to $5.61 in pre-market trading after falling 13% on Friday.</li>
<li>The Arena Group Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AREN#NYSE">AREN</a>) dipped 23.4% to $1.34 in pre-market trading. Arena Group shares jumped 207% on Friday after it announced its first ever profitable quarter.</li>
<li>Siyata Mobile Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYTA#NASDAQ">SYTA</a>) shares dipped 22.1% to $0.9895 in pre-market trading. Siyata Mobile recently reported better-than-expected third-quarter EPS results.</li>
<li>Eterna Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERNA#NASDAQ">ERNA</a>) fell 15% to $0.7100 in pre-market trading after dipping 12% on Friday.</li>
<li>Cyclerion Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCN#NASDAQ">CYCN</a>) fell 14% to $2.22 in pre-market trading after jumping more than 45% on Friday.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) fell 12.3% to $4.43 in pre-market trading after gaining around 9% on Friday. Kingsoft Cloud will release its unaudited financial results for the third quarter before the opening bell on Nov. 19.</li>
<li>Luminar Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) fell 9.3% to $0.8890 in today's pre-market trading after declining around 5% on Friday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42024062/how-to-earn-500-a-month-from-apple-stock">How To Earn $500 A Month From Apple Stock</a></li>
</ul>

Pre-Market Outlook

Markets

Movers

Trading Ideas

AEMD

APLM

AREN

ATCH

CMAX

CYCN

ERNA

FLYE

LAZR

LBRT

MNDR

NTLA

QMMM

SMCI

SYTA

TSLA

VVPR

Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

HCW Biologics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCWB#NASDAQ">HCWB</a>) stock is trading higher during Monday premarket with a strong session volume of 10.03 million versus an average volume of 48.02K, as per data from <a target="_blank" href="https://www.benzinga.com/pro/feature/newsfeed" rel="noreferrer noopener">Benzinga Pro</a>.
HCW Biologics and WY Biotech Co., Ltd., a China-based company specializing in the early-stage development of recombinant protein drugs and gene/cell therapies, have entered into a worldwide exclusive<a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g42032821/hcw-biologics-and-wy-biotech-announce-license-agreement-for-immunotherapeutic-product-candidate" rel="noreferrer noopener"> license agreement</a>.
The agreement covers the development and commercialization of one of HCW Biologics&#8217; product candidates generated with its new drug discovery platform for therapeutic use.
WY Biotech has agreed to pay HCW Biologics $7.0 million upfront. HCW Biologics is eligible to receive additional significant development milestone payments and double-digit royalties on future product sales.
In addition, HCW Biologics will share a substantial portion of the proceeds from a future transaction(s) involving the molecule if such a transaction occurs.
HCW Biologics also has a payment-free, milestone-free, and royalty-free option to recapture the development and commercialization rights of this molecule for the United States, Canada, Central America, and South America (Opt-in Territory) after the conclusion of the Phase 1 clinical trial.
WY Biotech is financially responsible for all costs associated with the molecule&#8217;s research and development, manufacturing, clinical development, regulatory approval, and commercialization.
If HCW Biologic exercises its opt-in rights, it will be responsible for costs associated with clinical development, regulatory approval, and commercialization in the Opt-in Territory.
As of September 30, 2024, the company said that substantial doubt exists regarding its ability to continue as a going concern for at least 12 months without additional <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g41991935/hcw-biologics-reports-third-quarter-2024-financial-results-and-business-highlights" rel="noreferrer noopener">funding or financial support</a>.
The company launched a multi-faceted financing plan in the third quarter of 2024 to raise the capital required through equity financings and business development transactions to fund future product development and operations.
Price Action: HCWB stock is up 237% at $0.99 during the premarket session at last check Monday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42032495/alibaba-eyes-5-billion-bond-sale-to-fund-debt-payoff-and-stock-buybacks" target="_blank" rel="noreferrer noopener">Alibaba Eyes Raising $5 Billion Via Bond Sale to Fund Debt Payoff and Stock Buybacks</a></li>
</ul>

Biotech

Equities

Penny Stocks

Health Care

Contracts

General

HCWB

Why Is Penny Stock HCW Biologics Surging On Monday?

Stephens &amp; Co. analyst Sudan Loganathan initiates coverage on Arvinas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>) with a Overweight rating and announces Price Target of $55.

ARVN

Stephens & Co. Initiates Coverage On Arvinas with Overweight Rating, Announces Price Target of $55

The social media landscape saw major shakeups following Elon Musk&#8216;s<a href="https://www.benzinga.com/news/23/04/31810229/elon-musk-bought-twitter-1-year-ago-a-look-back-at-whats-happened-since-and-what-could-be-next"> acquisition of Twitter</a> in 2022. Meta Platforms Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) Threads and former Twitter entity Bluesky quickly positioned itself as rivals to Musk&#8217;s controversial platform.
Two years on, where does the market stand?
The History: Musk bought Twitter in 2022 for $44 billion, citing his desire to maintain free speech on the platform and cut back on content moderation. The polarizing entrepreneur, who has become a close ally of President-elect Donald Trump, proceeded to rename the site to &#8220;X,&#8221; though most<a href="https://www.benzinga.com/news/23/09/34762870/is-it-twitter-or-x-heres-what-benzinga-users-call-elon-musks-social-media-platform"> users still refer</a> to it as Twitter.
Several advertisers <a href="https://www.benzinga.com/news/24/09/40762349/x-faces-major-advertiser-exodus-amid-string-of-elon-musk-controversies">left X following concerns</a> over the platform&#8217;s content moderation policies and public statements by Elon Musk, which some critics argue have contributed to the rise of harmful content. Musk has faced criticism for sharing information that has been labeled as misleading by some.
Bluesky, a former project of Twitter founder Jack Dorsey, has<a href="https://www.benzinga.com/news/24/09/40994909/elon-musks-x-bled-users-to-bluesky-in-uk-since-the-tech-mogul-started-posting-things-like-civil-war"> also gained popularity</a> as an alternative to X.
The Metrics: Musk&#8217;s investment has not proven to be fruitful—in October, Fidelity<a href="https://www.benzinga.com/top-stories/24/10/41603930/trump-vs-musk-djt-stock-worth-more-than-latest-x-valuation-thanks-to-2024-election-run-up"> valued the platform</a> at $9.4 billion, representing a nearly 80% drop from Musk&#8217;s purchase price.
Despite the major reduction in valuation, X still seems to be the most prominent of the three platforms.
Musk&#8217;s website<a href="https://www.benzinga.com/general/social-media/24/10/41657772/musk-thinks-threads-is-boring-but-275-million-monthly-users-signal-zuckerbergs-platform-coul"> boasts a purported</a> 600 million monthly active users; Threads lags at 275 million monthly active users. Another estimate of activity puts X at 251 million daily active users.
While X supports advertising, Threads is<a href="https://www.benzinga.com/news/24/08/40523059/mark-zuckerbergs-twitter-clone-threads-explores-ad-integration-but-company-says-there-is-no-immediat"> not yet monetized</a>.
The Future: Musk&#8217;s association with Donald Trump and potential involvement in his cabinet has drawn mixed reactions from X users, with some expressing dissatisfaction. Following Trump&#8217;s election win on Nov. 5, NBC <a href="https://www.nbcnews.com/tech/tech-news/x-sees-largest-user-exodus-musk-takeover-rcna179793">reported </a>that over 100,000 users left the platform in a single day, marking a notable moment during Musk&#8217;s tenure.
Many of those users flocked to Bluesky. While the newcomer only has 14.5 million users, it has added over a million since the election,<a href="https://www.thewrap.com/bluesky-social-users-increase-x-elon-musk-twitter/"> according</a> to The Wrap. This may accelerate in the coming months.
Several experts have posited that social media websites&#8217; user bases will become bifurcated by political ideology amid a period of increased polarization. 
To some extent, this may have already happened—when Musk<a href="https://www.benzinga.com/news/24/08/40476241/elon-musk-conducts-a-super-unscientific-poll-to-gauge-voter-preference-between-trump-and-harris-here"> polled his followers</a> in August on who they planned to vote for, 73.2% responded that they&#8217;d vote for Trump. Thus, if X was a state, it would be the most conservative in the entire United States, redder than West Virginia and Wyoming.
Bluesky, Threads and possibly Reddit Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) would benefit from further polarization and a push toward users aligning social media choices with personal ideology.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/11/42015996/tesla-to-partner-with-lyft-uber-analyst-says-rising-conviction-for-partnership-in-future">Tesla To Partner With Lyft, Uber? Analyst Has &#8216;Rising Conviction&#8217; For Future Partnership</a></li>
</ul>
Photo: Shutterstock

Social Media

Politics

Tech

RDDT

X Vs. Threads Vs. Bluesky: Does Elon Musk's Social Media Site Still Reign Supreme?

U.S. stocks settled lower on Friday, with the Dow Jones falling more than 300 points during the session. The S&amp;P 500 recorded a weekly loss of 2.1%, while the Nasdaq Composite fell around 3.2%. The 30-stock Dow lost 1.2% during the week.
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst&#8217;s opinion to trust.
Benzinga&#8217;s Analyst Ratings API is a collection of the highest-quality stock ratings curated by the Benzinga news desk via direct partnerships with major sell-side banks. Benzinga displays overnight ratings changes on a daily basis three hours prior to the U.S. equity market opening. Data specialists at investment dashboard provider Toggle.ai recently uncovered that the analyst insights Benzinga Pro subscribers and Benzinga readers regularly receive can successfully be used as trading indicators to outperform the stock market.
Top Analyst Picks: Fortunately, any Benzinga reader can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. One of the ways traders can sort through Benzinga&#8217;s extensive database of analyst ratings is by analyst accuracy. Here&#8217;s a look at the most recent stock picks from each of the five most accurate Wall Street analysts, according to Benzinga <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock</a> Ratings.
Analyst: John Todaro
<ul>
<li>Analyst Firm: Needham</li>
<li>Ratings Accuracy: 90%</li>
<li>Latest Rating: Maintained a Buy rating on Hut 8 Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>) and raised the price target from $21 to $32 on Nov. 14. This analyst sees more than 25% increase in the stock.</li>
<li>Recent News: On Nov. 13, Hut 8 Mining reported better-than-expected third-quarter financial results.</li>
</ul>
Analyst: Trevor Walsh
<ul>
<li>Analyst Firm: JMP Securities</li>
<li>Ratings Accuracy: 89%</li>
<li>Latest Rating: Maintained a Market Outperform rating on Cyberark Software Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>) and boosted the price target from $310 to $360 on Nov. 14. This analyst sees around 18% upside in the stock.</li>
<li>Recent News: On Nov. 13, CyberArk Software reported better-than-expected earnings for its third quarter.</li>
</ul>
Analyst: Mike Colonnese
<ul>
<li>Analyst Firm: HC Wainwright &amp; Co.</li>
<li>Ratings Accuracy: 87%</li>
<li>Latest Rating: Maintained a Buy rating on HIVE Digital Technologies Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIVE#NASDAQ">HIVE</a>) and raised the price target from $5 to $8 on Nov. 14. This analyst sees around 77% upside in the stock.</li>
<li>Recent News: On Nov. 14, HIVE Digital Technologies posted mixed quarterly results.</li>
</ul>
Analyst: Josh Sullivan
<ul>
<li>Analyst Firm: Benchmark</li>
<li>Ratings Accuracy: 86%</li>
<li>Latest Rating: Maintained a Buy rating on Intuitive Machines Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) and increased the price target from $10 to $16 on Nov. 15. This analyst sees around 31% surge in the stock.</li>
<li>Recent News: On Nov. 14, Intuitive Machines reported third-quarter revenue of $58.48 million, beating analyst estimates of $50.89 million, according to Benzinga Pro.</li>
</ul>
Analyst: Rufus Hone
<ul>
<li>Analyst Firm: BMO Capital</li>
<li>Ratings Accuracy: 86%</li>
<li>Latest Rating: Maintained an Outperform rating on Mastercard Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) and raised the price target from $550 to $565 on Nov. 14. This analyst sees more than 8% upside in the stock.</li>
<li>Recent News: Mastercard, last week, unveiled its vision to transform online shopping by 2030, aiming to eliminate the need for physical card numbers, passwords, and one-time codes to streamline the checkout experience.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42024062/how-to-earn-500-a-month-from-apple-stock">How To Earn $500 A Month From Apple Stock</a></li>
</ul>

Earnings

CYBR

HIVE

LUNR

This Analyst With 86% Accuracy Rate Sees Over 8% Upside In Mastercard - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts

As of Nov. 18, 2024, three stocks in the communication services sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">LQR House Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQR#NASDAQ">LQR</a>)</h3>
<ul>
<li>On Nov. 4, LQR House reports October revenue of $238,159.57 up from $45,400 in the year-ago period. Sean Dollinger, CEO of LQR House, commented, &#8220;I&#8217;m not sure everyone realizes just how valuable these partnerships are-they&#8217;re monthly recurring revenue from brands paying for our marketing services, including banner ads, email campaigns, and influencer content. Each of these drives traffic and sales on CWSpirits.com, which we own. We&#8217;re incredibly proud of each new partner that trusts us with their brand&#8217;s growth, and we believe that October&#8217;s results are a testament to the platform&#8217;s strength.&#8221; The company's stock gained around 78% over the past month and has a <a href="https://www.benzinga.com/quote/LQR">52-week high of $3.47</a>.</li>
<li>RSI Value: 82.00&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>LQR Price Action: Shares of LQR gained 10.9% to close at $1.00 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Cineverse Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNVS#NASDAQ">CNVS</a>)</h3>
<ul>
<li>On Nov. 14, Cineverse reported better-than-expected second-quarter financial results. The company's stock gained around 40% over the past month and <a href="https://www.benzinga.com/quote/CNVS">has a 52-week high</a> of $3.93.</li>
<li>RSI Value: 74.14</li>
<li>CNVS Price Action: Shares of Cineverse gained 23.1% to close at $3.20 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Arena Group Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AREN#NYSE">AREN</a>)</h3>
<ul>
<li>On Nov. 14, The Arena Group delivered the first quarter of positive net income. The Arena Group CEO Sara Silverstein said, "We're achieving meaningful revenue diversification, including a significant increase in e-commerce and other revenue, enabling a substantial improvement in profitability. We generated higher gross margins, returned to positive operating income, and delivered our first-ever quarter of positive net income." The company's stock gained around 200% over the past five days and has a <a href="https://www.benzinga.com/quote/AREN">52-week high</a> of $4.74.</li>
<li>RSI Value: 91.13</li>
<li>AREN Price Action: Shares of Arena Group gained 207% to close at $1.75 on Friday. </li>
</ul>
Read More:
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42024062/how-to-earn-500-a-month-from-apple-stock"> How To Earn $500 A Month From Apple Stock</a></li>
</ul>

Short Ideas

CNVS

Top 3 Tech And Telecom Stocks That May Implode This Month

D. Boral Capital analyst Jason Kolbert initiates coverage on Lineage Cell Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LCTX#AMEX">LCTX</a>) with a Buy rating and announces Price Target of $3.

LCTX

D. Boral Capital Initiates Coverage On Lineage Cell Therapeutics with Buy Rating, Announces Price Target of $3

U.S. stock futures were mixed this morning, with the Dow futures falling more than 100 points on Monday.
Shares of Neurogene Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NGNE#NASDAQ">NGNE</a>) fell sharply in today's pre-market trading after the company announced it brought its high-dose gene therapy trial to a halt after a serious adverse event in a Rett <a href="https://www.benzinga.com/quote/NGNE">syndrome patient</a>.
Neurogene shares declined 37.7% to $21.50 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Rezolve AI Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLV#NASDAQ">RZLV</a>) shares tumbled 16.1% to $2.29 in pre-market trading after dipping over 20% on Friday.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) shares dipped 12.3% to $4.43 in pre-market trading after gaining around 9% on Friday. Kingsoft Cloud will release its unaudited financial results for the third quarter before the opening bell on Nov. 19.</li>
<li>Luminar Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) tumbled 9.3% to $0.8890 in today's pre-market trading after declining around 5% on Friday.</li>
<li>Omeros Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMER#NASDAQ">OMER</a>) shares fell 7% to $6.28 in pre-market trading.</li>
<li>CompoSecure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPO#NASDAQ">CMPO</a>) shares declined 5.9% to $13.00 in pre-market trading.</li>
<li>Amgen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>) shares fell 5.4% to $266.21 in pre-market trading following a 4% decline on Friday.</li>
<li>Intuitive Machines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) shares fell 5% to $11.80 in pre-market trading after jumping 21% on Friday.</li>
<li>ProQR Therapeutics N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRQR#NASDAQ">PRQR</a>) shares fell 4% to $3.67 in pre-market trading.</li>
<li>NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) shares fell 2.4% to $138.51 in pre-market trading after declining more than 3% on Friday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42024062/how-to-earn-500-a-month-from-apple-stock">How To Earn $500 A Month From Apple Stock</a></li>
</ul>

AMAT

AMGN

CMPO

NGNE

NVDA

OMER

PRQR

RZLV

Neurogene, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Stock Split

GSAT

Globalstar Announced That Its Board Of Directors Has Authorized A Reverse Stock Split Of Its Common Stock, Which Is Also Expected To Take Place In Q1 2025 At A Ratio To Be Determined Closer To The Effective Date

MARA Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) shares are trading lower by 5.6% to $19.90 Monday morning after the company announced a <a href="https://www.benzinga.com/pressreleases/24/11/g42032618/mara-holdings-inc-announces-proposed-private-offering-of-700-million-of-convertible-senior-notes">$700 million convertible note offering</a> to boost its Bitcoin holdings and repurchase debt.
What To Know: MARA Holdings announced a private offering of $700 million in convertible senior notes due 2030, with an option for initial purchasers to buy an additional $105 million. 
The company says the notes will bear semi-annual interest starting March 1, 2025, and mature on March 1, 2030, unless earlier converted, redeemed or repurchased. 
Redemption and conversion terms include conditions beginning in 2027 and 2028, respectively. Proceeds will be used to repurchase existing 2026 convertible notes, acquire bitcoin and support corporate purposes, including debt repayment and strategic expansion.
MARA meanwhile says the repurchase of 2026 notes may lead to market activity, as hedged holders could buy MARA stock or adjust derivative positions, potentially impacting MARA's stock price and the conversion price of the new notes. The final terms, including the interest rate and conversion rate, will be set at pricing.
Read Also: <a href="https://www.benzinga.com/24/11/42028342/blackwell-backfires-nvidias-ai-chips-struggle-with-server-overheating-impacting-meta-microsoft-and-musks-xai-data-centers">Nvidia&#8217;s Blackwell Chips Are Extra Toasty, Server Overheating Issues Impact Meta, Microsoft And Elon Musk&#8217;s xAI</a>
<h2 class="wp-block-heading">How To Buy MARA Stock</h2>
By now you're likely curious about how to participate in the market for MARA Holdings &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so. 
In the the case of MARA Holdings, which is trading at $21.07 as of publishing time, $100 would buy you 4.75 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, MARA has a 52-week high of $34.09 and a 52-week low of $9.21.

MARA

Why Bitcoin-Related Stock MARA Holdings Is Falling

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Needham analyst Ami Fadia downgraded the rating for Biogen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) from Buy to Hold and maintained the price target of $270. Biogen shares closed at $159.99 on Friday. <a href="https://www.benzinga.com/quote/BIIB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wolfe Research analyst Jacob Lacks downgraded the rating for Matson, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MATX#NYSE">MATX</a>) from Outperform to Peer Perform. Matson shares closed at $160.65 on Friday. <a href="https://www.benzinga.com/quote/MATX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Nicholas Campanella downgraded Pinnacle West Capital Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNW#NYSE">PNW</a>) from Overweight to Equal-Weight and lowered the price target from $93 to $91. Pinnacle West Capital shares closed at $91.88 on Friday. <a href="https://www.benzinga.com/quote/PNW/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Argus Research analyst John Eade downgraded the rating for Fortive Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTV#NYSE">FTV</a>) from Buy to Hold. Fortive shares closed at $74.82 on Friday. <a href="https://www.benzinga.com/quote/FTV/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel analyst Nathan Jones downgraded Curtiss-Wright Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CW#NYSE">CW</a>) from Buy to Hold and maintained the price target of $370. Curtiss-Wright shares closed at $358.35 on Friday. <a href="https://www.benzinga.com/quote/CW/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying BIIB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="548" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/18081441/image-183-1024x548.png" alt="" class="wp-image-652880" style="width:643px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/18081441/image-183-1024x548.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/18081441/image-183-300x161.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/18081441/image-183-768x411.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/18081441/image-183.png 1237w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42024062/how-to-earn-500-a-month-from-apple-stock">How To Earn $500 A Month From Apple Stock</a></li>
</ul>

Downgrades

BFAM

BIIB

MATX

This Biogen Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Royal Bank of Canada (RY) Q2 2024 Earnings Call Transcript

ClearBridge Canadian Equity Strategy Q2 2024 Commentary

ClearBridge Canadian Dividend Strategy Q2 2024 Commentary

FPF: This High-Yielding CEF Is Taking Steps To Protect Itself Against Banking Problems

Royal Bank of Canada 2024 Q3 - Results - Earnings Call Presentation

Royal Bank of Canada (RY) Q3 2024 Earnings Call Transcript

Royal Bank of Canada (RY) Annual Scotiabank Financials Summit (Transcript)

Royal Bank of Canada (RY) Barclays 22nd Annual Global Financial Services Conference (Transcript)

Comments

Royal Bank of Canada Non Cum 1st Pfd Registered Shs Series -AZ-

Royal Bank of Canada Non Cum 1st Pfd Registered Shs Series -AZ- (RYBPF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga